John P Curtin
Overview
Explore the profile of John P Curtin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frey M, Lee S, Gerber D, Schwartz Z, Martineau J, Lutz K, et al.
Gynecol Oncol
. 2020 Feb;
157(1):280-286.
PMID: 32057464
Background: Timely genetic testing at ovarian cancer diagnosis is essential as results impact front line treatment decisions. Our objective was to determine rates of genetic counseling and testing with an...
2.
Khouri O, Frey M, Musa F, Muggia F, Lee J, Boyd L, et al.
Cancer Chemother Pharmacol
. 2019 Apr;
84(2):281-285.
PMID: 30980132
Objectives: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is a treatment strategy for ovarian cancer patients with unresectable disease or poor performance status (PS). This strategy has been...
3.
Lee J, Curtin J, Muggia F, Pothuri B, Boyd L, Blank S
Cancer Chemother Pharmacol
. 2018 Apr;
82(1):55-63.
PMID: 29704010
Purpose: To evaluate the outcomes of intraperitoneal chemotherapy (IP) compared with those of intravenous chemotherapy (IV) in patients with advanced ovarian cancer after neoadjuvant chemotherapy (NACT) and interval debulking surgery...
4.
Lee J, Gerber D, Aphinyanaphongs Y, Curtin J, Boyd L
Gynecol Oncol
. 2018 Apr;
149(1):22-27.
PMID: 29605045
Objectives: Black race has been associated with increased 30-day morbidity and mortality following surgery for endometrial cancer. Black women are also less likely to undergo laparoscopy when compared to white...
5.
Schwartz Z, Frey M, Philips S, Curtin J
Gynecol Oncol
. 2017 Jul;
146(3):514-518.
PMID: 28734496
Objectives: In June 2011, the SGO recommended that physical exam and symptoms be the primary surveillance methods in patients with endometrial cancer. We sought to evaluate adherence to these guidelines...
6.
Frey M, Blank S, Curtin J
Am Soc Clin Oncol Educ Book
. 2017 Jun;
37:23-28.
PMID: 28561642
No abstract available.
7.
Frey M, Sandler G, Sobolev R, Kim S, Chambers R, Bassett R, et al.
Gynecol Oncol
. 2017 May;
146(1):123-128.
PMID: 28495237
Objective: To evaluate the results of multigene panel testing among Ashkenazi Jewish compared with non-Ashkenazi Jewish patients. Methods: We reviewed the medical records for all patients who underwent multigene panel...
8.
Lee J, Aphinyanaphongs Y, Curtin J, Chern J, Frey M, Boyd L
Gynecol Oncol
. 2016 Jun;
142(3):508-13.
PMID: 27288543
Objective: To determine factors influencing discharge patterns after laparoscopic hysterectomy for endometrial cancer and to evaluate the safety of same-day discharge during the 30-day postoperative period. Methods: Using the American...
9.
Musa F, Alard A, David-West G, Curtin J, Blank S, Schneider R
Mol Cancer Ther
. 2016 May;
15(7):1557-67.
PMID: 27196780
There is considerable interest in the clinical development of inhibitors of mTOR complexes mTORC1 and 2. Because mTORC1 and its downstream mRNA translation effectors may protect against genotoxic DNA damage,...
10.
Frey M, Moss H, Musa F, Rolnitzky L, David-West G, Chern J, et al.
Cancer
. 2016 Mar;
122(6):859-67.
PMID: 26938270
Background: Widespread disparities in care have been documented in women with gynecologic cancer in the United States. This study was designed to determine whether structural barriers to optimal care were...